Tympanic Thermometers Accuracy

January 24, 2025 updated by: Istituto Ortopedico Rizzoli

The Diagnostic Accuracy and Precision of the Latest Generation Tympanic Thermometers in the Adult and Paediatric Population: Multicentre Cross-sectional Study

The aim of the present study is to evaluate the measurement precision and accuracy of the third-generation tympanic thermometer in relation to the measurement modalities considered gold standard. The evaluation of the instrument will be conducted in relation to the different calibration times of the tympanic thermometer, the level of re-training of healthcare personnel in the use of the instrument and the adult and paediatric population subjected to the measurement. Finally, the diagnostic capacity of the instrument in correctly identifying states of hypothermia and febrile elevations will be assessed.

Study Overview

Status

Completed

Conditions

Detailed Description

The temperature measurement will be taken on each patient enrolled at a single time by the caregiver for that patient. As the measurements do not depend on which side they are taken, the most convenient side will be chosen. Each patient will only be included once

The research nurse will record the core temperature from the monitor on the CRF and, within the next 5 minutes, take the peripheral temperature with the tympanic thermometer three times in a row, recording all three values on the CRF. Subsequently a second operator will always take the temperature 3 times within 5 minutes of the gold standard measurement. The gold standard (reference tests), as indicated in the literature, can be either the thermometer inserted in the probe placed in the pulmonary artery, or the thermometer inserted in the bladder catheter or oesophageal probe, or directly a rectal thermometer.

Only the first tympanic measurement will then be used to assess accuracy against the gold standard. The other measurements above will only be evaluated for inter and intra reliability. The unit under study is therefore the individual patient at a precise point in time

Study Type

Observational

Enrollment (Actual)

1100

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Alessandria, Italy, 15121
        • ASO Azienda Ospedaliera Nazionale SS Antonio e Biagio e Cesare Arrigo
      • Bologna, Italy, 40136
        • Istituto Ortopedico Rizzoli
      • Bologna, Italy, 40138
        • Policlinico di S.Orsola Azienda Ospedaliero-Universitaria di Bologna
      • Firenze, Italy, 50139
        • Azienda Ospedaliera Universitaria Meyer Istituto di Ricovero e Cura a Carattere Scientifico
      • Pavia, Italy, 27100
        • Fondazione IRCCS Policlinico San Matteo
      • Trento, Italy, 38123
        • APSS Trento
      • Verona, Italy, 37126
        • Azienda Ospedaliera Universitaria Integrata di Verona

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Child
  • Adult
  • Older Adult

Accepts Healthy Volunteers

No

Sampling Method

Non-Probability Sample

Study Population

patients admitted to acute hospitals

Description

Inclusion Criteria:

  • Paediatric patients over the age of 4 months
  • adults admitted to intensive care and resuscitation
  • undergoing surgery who by current practice undergo invasive core temperature measurement

Exclusion Criteria:

  • Patients with bilateral auricular inflammatory problems,
  • patients who will not use the gold standard for clinical reasons,
  • patients or legal guardians who do not consent to participate in the study.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

Cohorts and Interventions

Group / Cohort
Intervention / Treatment
in-patients requiring temperature monitoring
The patient at any age whose core temperature is monitored during hospitalisation
The patient whose core temperature is monitored during hospitalisation has his temperature at tympanic level taken once during the stay. The research nurse will record the core temperature from the monitor on the CRF and, within the next 5 minutes, take the peripheral temperature with the tympanic thermometer three times in a row, recording all three values on the CRF. Subsequently a second operator will always take the temperature 3 times within 5 minutes of the gold standard measurement. Only the first tympanic measurement will then be used to assess accuracy against the gold standard.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Measure of Agreement
Time Frame: The temperature measurement will be taken on each patient enrolled up to 2 weeks
Measure of Agreement between the thermometer and the gold standard to be assessed by the Bland and Altman method.
The temperature measurement will be taken on each patient enrolled up to 2 weeks

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
accuracy
Time Frame: The temperature measurement will be taken on each patient enrolled up to 2 weeks
sensitivity, specificity, predictive values, likelihood ratios
The temperature measurement will be taken on each patient enrolled up to 2 weeks

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

December 28, 2023

Primary Completion (Actual)

October 31, 2024

Study Completion (Actual)

October 31, 2024

Study Registration Dates

First Submitted

October 18, 2023

First Submitted That Met QC Criteria

October 24, 2023

First Posted (Actual)

October 27, 2023

Study Record Updates

Last Update Posted (Actual)

March 25, 2025

Last Update Submitted That Met QC Criteria

January 24, 2025

Last Verified

January 1, 2025

More Information

Terms related to this study

Other Study ID Numbers

  • 507/2023/Oss/IOR

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Fever

Clinical Trials on latest generation tympanic thermometer

Subscribe